The Research and Development team at STORM Therapeutics focuses on innovating and optimizing small molecule inhibitors that target RNA-modifying enzymes for cancer treatment. This multidisciplinary team of scientists, including principal and senior scientists across various specialties, collaborates on drug discovery, preclinical research, and translational oncology to advance novel therapeutic candidates from concept to clinical evaluation. Their work is pivotal in leveraging RNA epigenetics to create effective cancer therapies.
View all